Home › Companies › VIRIDIAN THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and VIRIDIAN THERAPEUTICS INC.’s Form 8-K, filed June 20, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 17, 2024: 5 items on VIRIDIAN THERAPEUTICS INC.’s Form 8-K, filed June 20, 2024: 2 elected · 3 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore VIRIDIAN THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are VIRIDIAN THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 20, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Stephen Mahoney | 56,413,440 | -- | -- | 156,106 | 1,902,188 | 99.7% | Elected | — |
| Elect Director: Arlene M. Morris | 31,631,097 | -- | -- | 24,938,449 | 1,902,188 | 56% | Elected | — |
| 2. Ratification of the selection of KPMG LLP as the Company's independent auditor for 2024 | 58,418,569 | 31,748 | 21,417 | -- | -- | 99.9% | Not verified | — |
| 3. Approval, on an advisory basis, of the compensation of the Company's named executive officers | 32,797,468 | 23,748,216 | 23,862 | -- | 1,902,188 | 58% | Not verified | — |
| 4. Approval of a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including an increase by 2,000,000 of the shares available for issuance thereunder | 32,220,474 | 24,328,888 | 20,184 | -- | 1,902,188 | 57% | Not verified | — |
Source: VIRIDIAN THERAPEUTICS INC., Form 8-K, filed with the SEC on June 20, 2024 — read the filing on EDGAR.
Each item below shows how the 162 asset managers that disclosed a VIRIDIAN THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
56% Majority: yes · of votes cast
Description as filed by funds: To elect the two Class III director nominees to serve until the 2027 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Arlene M. Morris
VIRIDIAN THERAPEUTICS INC.’s own tally for this item (“Elect Director: Arlene M. Morris”): 31,631,097 for, 24,938,449 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and the other proposals voted on were approved.”
Support: 56% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 48 asset managers below reported 6,636,994 for, 14,033,061 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,093,206 | 0 | 0 | 8,555,686 | Mixed |
| Vanguard | 3,062,031 | 0 | 0 | 0 | For |
| State Street | 3,116 | 0 | 0 | 2,941,945 | Withhold |
| TIAA | 1,251,611 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 1,014,023 | Withhold |
| BlackRock | 939,518 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 427,042 | Withhold |
| Principal | 0 | 0 | 0 | 223,969 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 191,602 | Withhold |
| Russell Investments | 0 | 0 | 0 | 131,754 | Withhold |
| Equitable | 77,573 | 0 | 0 | 38,700 | Mixed |
| CARILLON SERIES TRUST | 0 | 0 | 0 | 115,998 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 92,719 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 69,048 | Withhold |
| Nushares ETF Trust | 46,665 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 38,954 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 35,700 | Withhold |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 35,035 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 24,515 | Withhold |
| Brighthouse | 0 | 0 | 0 | 22,618 | Withhold |
| Northern Trust | 22,008 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 20,792 | Withhold |
| John Hancock | 0 | 0 | 0 | 18,538 | Withhold |
| Nationwide | 0 | 0 | 0 | 17,957 | Withhold |
| Pacific Life | 17,550 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: To elect the two Class III director nominees to serve until the 2027 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Stephen Mahoney
VIRIDIAN THERAPEUTICS INC.’s own tally for this item (“Elect Director: Stephen Mahoney”): 56,413,440 for, 156,106 withheld, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and the other proposals voted on were approved.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 48 asset managers below reported 20,656,268 for, 13,787 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,648,892 | 0 | 0 | 0 | For |
| Vanguard | 3,062,031 | 0 | 0 | 0 | For |
| State Street | 2,945,061 | 0 | 0 | 0 | For |
| TIAA | 1,251,611 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,014,023 | 0 | 0 | 0 | For |
| BlackRock | 939,518 | 0 | 0 | 0 | For |
| Charles Schwab | 427,042 | 0 | 0 | 0 | For |
| Principal | 223,969 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 191,602 | 0 | 0 | 0 | For |
| Russell Investments | 131,754 | 0 | 0 | 0 | For |
| Equitable | 116,273 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 115,998 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 92,719 | 0 | 0 | 0 | For |
| ProShares | 69,048 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 46,665 | 0 | 0 | 0 | For |
| Dimensional | 38,954 | 0 | 0 | 0 | For |
| Lincoln Financial | 35,700 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 35,035 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 24,515 | 0 | 0 | 0 | For |
| Brighthouse | 8,831 | 0 | 0 | 13,787 | Mixed |
| Northern Trust | 22,008 | 0 | 0 | 0 | For |
| Global X | 20,792 | 0 | 0 | 0 | For |
| John Hancock | 18,538 | 0 | 0 | 0 | For |
| Nationwide | 17,957 | 0 | 0 | 0 | For |
| Pacific Life | 17,550 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 3 wordings of this item as funds reported it.
57% Majority: yes · of votes cast
Description as filed by funds: To approve a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including to increase the number of shares available for issuance thereunder.
VIRIDIAN THERAPEUTICS INC.’s own tally for this item (“4. Approval of a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including an increase by 2,000,000 of the shares available for issuance thereunder”): 32,220,474 for, 24,328,888 against, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 57% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,093,206 | 8,555,686 | 0 | 0 | Mixed |
| Vanguard | 3,062,031 | 0 | 0 | 0 | For |
| State Street | 3,116 | 2,941,945 | 0 | 0 | Against |
| TIAA | 1,251,611 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 1,014,023 | 0 | 0 | Against |
| BlackRock | 939,518 | 0 | 0 | 0 | For |
| Charles Schwab | 427,042 | 0 | 0 | 0 | For |
| Principal | 164 | 223,805 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 191,602 | 0 | 0 | Against |
| Russell Investments | 131,754 | 0 | 0 | 0 | For |
| Equitable | 77,573 | 38,700 | 0 | 0 | Mixed |
| CARILLON SERIES TRUST | 0 | 115,998 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 92,719 | 0 | 0 | 0 | For |
| ProShares | 0 | 69,048 | 0 | 0 | Against |
| Nushares ETF Trust | 46,665 | 0 | 0 | 0 | For |
| Dimensional | 0 | 38,954 | 0 | 0 | Against |
| Lincoln Financial | 0 | 35,700 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 0 | 35,035 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 24,515 | 0 | 0 | Against |
| Brighthouse | 0 | 8,831 | 13,787 | 0 | Mixed |
| Northern Trust | 0 | 22,008 | 0 | 0 | Against |
| Global X | 20,792 | 0 | 0 | 0 | For |
| John Hancock | 0 | 18,538 | 0 | 0 | Against |
| Nationwide | 396 | 17,561 | 0 | 0 | Against |
| Pacific Life | 17,550 | 0 | 0 | 0 | For |
Fund voting reports, all 49 managers: 7,211,881 for, 13,455,887 against, 13,787 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Yiheng Capital Management, L.P. | 668,236 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 12,191 | Withhold |
Institutional-manager reports, all 2 managers: 668,236 for, 12,191 withheld.
Combines 6 wordings of this item as funds reported it.
58% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers.
VIRIDIAN THERAPEUTICS INC.’s own tally for this item (“3. Approval, on an advisory basis, of the compensation of the Company's named executive officers”): 32,797,468 for, 23,748,216 against, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 58% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,072,270 | 8,576,622 | 0 | 0 | Mixed |
| Vanguard | 3,062,031 | 0 | 0 | 0 | For |
| State Street | 2,941,033 | 4,028 | 0 | 0 | For |
| TIAA | 1,251,611 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 1,014,023 | 0 | 0 | Against |
| BlackRock | 0 | 939,518 | 0 | 0 | Against |
| Charles Schwab | 0 | 427,042 | 0 | 0 | Against |
| Principal | 0 | 223,969 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 191,602 | 0 | 0 | Against |
| Russell Investments | 0 | 131,754 | 0 | 0 | Against |
| Equitable | 0 | 116,273 | 0 | 0 | Against |
| CARILLON SERIES TRUST | 0 | 115,998 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 92,719 | 0 | 0 | Against |
| ProShares | 0 | 69,048 | 0 | 0 | Against |
| Nushares ETF Trust | 46,665 | 0 | 0 | 0 | For |
| Dimensional | 0 | 38,954 | 0 | 0 | Against |
| Lincoln Financial | 35,700 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 35,035 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 24,515 | 0 | 0 | Against |
| Brighthouse | 0 | 8,831 | 13,787 | 0 | Mixed |
| Northern Trust | 22,008 | 0 | 0 | 0 | For |
| Global X | 0 | 20,792 | 0 | 0 | Against |
| John Hancock | 0 | 18,538 | 0 | 0 | Against |
| Nationwide | 0 | 17,957 | 0 | 0 | Against |
| Pacific Life | 0 | 17,550 | 0 | 0 | Against |
Fund voting reports, all 49 managers: 8,476,352 for, 12,191,416 against, 13,787 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 9,377,365 | 0 | 0 | Against |
| Paradigm Biocapital Advisors LP | 0 | 4,778,003 | 0 | 0 | Against |
| State Street | 3,837,693 | 24,170 | 0 | 0 | For |
| VR Adviser, LLC | 3,082,670 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 3,039,360 | 0 | 0 | 0 | For |
| COMMODORE CAPITAL LP | 1,934,653 | 0 | 0 | 0 | For |
| Fairmount Funds Management LLC | 1,845,813 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 1,750,000 | 0 | 0 | 0 | For |
| Vivo Capital, LLC | 1,678,207 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 1,516,306 | 0 | 0 | Against |
| BlackRock | 9,127 | 1,412,506 | 0 | 0 | Against |
| Nuveen | 1,300,611 | 0 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 1,286,160 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 1,255,966 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,158,915 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 0 | 987,650 | 0 | 0 | Against |
| Polar Capital Holdings Plc | 0 | 882,660 | 0 | 0 | Against |
| 5AM Venture Management, LLC | 736,595 | 0 | 0 | 0 | For |
| Citadel | 727,030 | 0 | 0 | 0 | For |
| Yiheng Capital Management, L.P. | 668,236 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 622,029 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 620,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 456,716 | 0 | 0 | Against |
| Northern Trust | 375,775 | 1,729 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 280,000 | 0 | 0 | Against |
Institutional-manager reports, all 130 managers: 26,942,774 for, 21,920,164 against, 12,191 withheld. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.
VIRIDIAN THERAPEUTICS INC.’s own tally for this item (“2. Ratification of the selection of KPMG LLP as the Company's independent auditor for 2024”): 58,418,569 for, 31,748 against, per its Form 8-K filed June 20, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 20,667,298 for, 470 against, 13,787 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 9,648,892 | 0 | 0 | 0 | For |
| Vanguard | 3,062,031 | 0 | 0 | 0 | For |
| State Street | 2,944,591 | 470 | 0 | 0 | For |
| TIAA | 1,251,611 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,014,023 | 0 | 0 | 0 | For |
| BlackRock | 939,518 | 0 | 0 | 0 | For |
| Charles Schwab | 427,042 | 0 | 0 | 0 | For |
| Principal | 223,969 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 191,602 | 0 | 0 | 0 | For |
| Russell Investments | 131,754 | 0 | 0 | 0 | For |
| Equitable | 116,273 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 115,998 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 92,719 | 0 | 0 | 0 | For |
| ProShares | 69,048 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 46,665 | 0 | 0 | 0 | For |
| Dimensional | 38,954 | 0 | 0 | 0 | For |
| Lincoln Financial | 35,700 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 35,035 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 24,515 | 0 | 0 | 0 | For |
| Brighthouse | 8,831 | 0 | 13,787 | 0 | Mixed |
| Northern Trust | 22,008 | 0 | 0 | 0 | For |
| Global X | 20,792 | 0 | 0 | 0 | For |
| John Hancock | 18,538 | 0 | 0 | 0 | For |
| Nationwide | 17,957 | 0 | 0 | 0 | For |
| Pacific Life | 17,550 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 63,798,536 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 15.12% |
| 2 | Vanguard | 4.80% |
| 3 | State Street | 4.62% |
| 4 | TIAA | 1.96% |
| 5 | AllianceBernstein | 1.59% |
| 6 | BlackRock | 1.47% |
| 7 | Charles Schwab | 0.67% |
| 8 | Principal | 0.35% |
| 9 | Direxion Shares ETF Trust | 0.30% |
| 10 | Russell Investments | 0.21% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.70% |
| 2 | Paradigm Biocapital Advisors LP | 7.49% |
| 3 | State Street | 6.05% |
| 4 | VR Adviser, LLC | 4.83% |
| 5 | Deep Track Capital, LP | 4.76% |
| 6 | COMMODORE CAPITAL LP | 3.03% |
| 7 | Fairmount Funds Management LLC | 2.89% |
| 8 | Novo Holdings A/S | 2.74% |
| 9 | Vivo Capital, LLC | 2.63% |
| 10 | AllianceBernstein | 2.38% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities affiliated with Fairmount Funds Management LLC | 21.88% | DEF14A |
| FMR (Fidelity) | 19.20% | 13F |
| Entities affiliated with FMR LLC | 11.95% | DEF14A |
| Entities affiliated with Venrock Healthcare Capital Partners | 8.71% | DEF14A |
| BlackRock | 8.51% | 13F |
| Entities affiliated with Deep Track Capital, LP | 8.43% | DEF14A |
| Entities affiliated with Paradigm BioCapital Advisors LP | 8.31% | DEF14A |
| State Street | 7.04% | 13F |
| Vanguard Group | 6.79% | 13F |
| Entities affiliated with Perceptive Advisors LLC | 6.30% | DEF14A |
Percentages above are of 63,798,536 shares outstanding, as reported by VIRIDIAN THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VIRIDIAN THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At VIRIDIAN THERAPEUTICS INC.'s shareholder meeting held June 17, 2024, in the 2023-2024 proxy season, 162 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,006 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers. — FOR was 58% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: VIRIDIAN THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 20, 2024.
VIRIDIAN THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.